News & Updates
Filter by Specialty:
Nomogram model predicts coronary artery lesions in recurrent KD patients
A newly constructed nomogram model demonstrates acceptable capacity in assessing the risk of coronary artery lesions (CAL) in patients with recurrent Kawasaki Disease (KD), according to a study.
Nomogram model predicts coronary artery lesions in recurrent KD patients
26 Jan 2024Tuberculosis in teens may be as severe as that in adults
Adolescents with tuberculosis (TB), especially those aged >15 years, may develop symptoms and conditions akin to those seen in adults with TB, suggests a study. In addition, there appears to be an increased incidence of severe pulmonary disease leading to pulmonary sequelae.
Tuberculosis in teens may be as severe as that in adults
26 Jan 2024Targeted HCV microelimination programme expanded after initial success
The University of Hong Kong’s (HKU) hepatitis C virus (HCV) microelimination programme targeting high-risk populations is expanded recently to eligible persons in custody (PICs) following initial success in individuals with history of illicit drug use, needle sharing or imprisonment undergoing rehabilitation in halfway houses or drug rehabilitation centres.
Targeted HCV microelimination programme expanded after initial success
26 Jan 2024Undervaccination tied to severe COVID-19 outcomes
In a meta-analysis of national cohort studies on COVID-19 vaccination across the UK (England, Northern Ireland, Scotland, and Wales), undervaccination was associated with a higher risk of severe COVID-19 outcomes (ie, COVID-19 hospitalization or death) relative to full vaccination.
Undervaccination tied to severe COVID-19 outcomes
23 Jan 2024Berdazimer gel reduces molluscum contagiosum lesions in children
An analysis of three randomized controlled trials (RCTs) has shown the efficacy and safety of berdazimer gel, a topical, antiviral, nitric oxide-releasing medication, in the treatment of molluscum contagiosum (MC) lesions in patients aged 6 months and older. Application-site pain and erythema are the most common adverse events (AEs) related to treatment.